Stay updated on Cabozantinib in Salivary Gland Cancer: Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Salivary Gland Cancer: Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page now displays the study record for a phase 2 cabozantinib trial in advanced salivary gland cancer, including its terminated status, eligibility criteria, study design, outcomes, and related publications.
    Difference
    51%
    Check dated 2026-11-09T13:42:34.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:53:35.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says that both “Artificial Intelligence” and “Super Intelligence” terminology may appear during the transition.
    Difference
    1%
    Check dated 2026-10-26T15:44:16.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.1 to v3.7.2; the page otherwise remains a 403 error screen.
    Difference
    0.2%
    Check dated 2026-10-19T20:39:47.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer site revision changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-13T03:53:22.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with a simple error screen and minimal navigation.
    Difference
    19%
    Check dated 2026-09-21T21:53:34.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Salivary Gland Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.